We advised the sales agents on the offering

Davis Polk advised the sales agents in connection with the SEC-registered at-the-market offering by GRAIL, Inc. of its common stock for up to an aggregate amount of $300 million. The common stock is listed on the Nasdaq Global Select Market under the symbol “GRAL.”

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies and state-of-the-art machine learning, software and automation to detect and identify multiple deadly cancer types in earlier stages.

The Davis Polk corporate team included partners Alan F. Denenberg and Beth LeBow and associates Julia Molo and Robb Dehney. The tax team included counsel Dustin Plotnick and associate David J. Beer. Partner David R. Bauer and associates Shreya R. Kundur and Nazli Ungan provided intellectual property advice. Members of the Davis Polk team are based in the Northern California and New York offices.

Copy link to share post